Does Dexmedetomidine Decrease the Incidence of Untoward Airway Events After Deep or Awake Extubation in Patients Undergoing Adenotonsillectomy With or Without Myringotomy and Tube Placement?

Trial Profile

Does Dexmedetomidine Decrease the Incidence of Untoward Airway Events After Deep or Awake Extubation in Patients Undergoing Adenotonsillectomy With or Without Myringotomy and Tube Placement?

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Apr 2017

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Sedation
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Oct 2015 Planned End Date changed from 1 Apr 2016 to 1 Feb 2018 as reported by ClinicalTrials.gov record.
    • 01 Oct 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Feb 2018 as reported by ClinicalTrials.gov record.
    • 11 Mar 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Apr 2015 to 1 Oct 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top